Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Recombinant Human VEGF-C (C-6His)

Product Specifications

Background

Vascular Endothelial Growth Factor (VEGF) -C is a member of the VEGF family, a group of polypeptide growth factors which play key roles in the physiology and pathology of many aspects of the cardiovascular system, including vasculogenesis, hematopoiesis, angiogenesis and vascular permeability. While VEGFC is homologous to other members of the VEGF/PDGF family, it contains the C-terminal propeptide which has an unusual structure with tandemly repeated cysteine-rich motifs. Upon biosynthesis, VEGFC is secreted as a non-covalent momodimer in an anti-parellel fashion. VEGF signalling in endothelial cells occurs through three tyrosine kinase receptors (VEGFRs) expressed by endothelial cells and hematopoietic precursors, and VEGF-C is a ligand for two receptors, VEGFR-3 (Flt4), and VEGFR-2. It is indicated that VEGFC undergoes a complex proteolytic maturation generating a variety of processed secreted forms with increased activity toward VEGFR-3, but only the fully processed form could activate VEGFR-2. VEGFC may function in angiogenesis of the venous and lymphatic vascular systems during embryogenesis, and also in the maintenance of differentiated lymphatic endothelium in adults. Knockout of the VEGF-C gene is embryonic lethal late in development, and although cells differentiate into the lymphatic lineage, they fail to sprout and form lymphatic vessels. Inactivation of a single VEGF-C allele results in the development of cutaneous lymphatic hypoplasia and lymphedema.

Product Name Alternative

Vascular Endothelial Growth Factor C; VEGF-C; Flt4 Ligand; Flt4-L; Vascular Endothelial Growth Factor-Related Protein; VRP; VEGFC

Accession Number

P49767

Host

Human Cells

Endotoxin

<1 EU/µg as determined by LAL test.

Purity

Greater than 95% as determined by reducing SDS-PAGE

Form

Lyophilized

Reconstitution

Always centrifuge tubes before opening.Do not mix by vortex or pipetting.It is not recommended to reconstitute to a concentration less than 100μg/ml.Dissolve the lyophilized protein in distilled water.Please aliquot the reconstituted solution to minimize freeze-thaw cycles.

Molecular Weight

23.27 KDa

Shipping Conditions

The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature listed below.

Storage Conditions

Store at -70°C/-20°C, stable for 6 months after receipt.Store at ≤-70°C, stable for 3 months under sterile conditions after opening. Please minimize freeze-thaw cycles.

Formulation

Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, 0.05% Tween80, pH8.0.

Construct

Recombinant Human Vascular Endothelial Growth Factor C is produced by our Mammalian expression system and the target gene encoding Phe32-Arg227 is expressed with a 6His tag at the C-terminus.

Species

Human

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

PLCG 2 Recombinant Antibody, PerCP Conjugated
bsm-62254R-PerCP 100 µL

PLCG 2 Recombinant Antibody, PerCP Conjugated

Sign In for Pricing
View Details
UGP2 Rabbit Polyclonal Antibody
AP21425BT-N 1 mL

UGP2 Rabbit Polyclonal Antibody

Sign In for Pricing
View Details
Breast Carcinoma-Amplified Sequence 4 (BCAS4) Antibody
abx014280-01 10 µg

Breast Carcinoma-Amplified Sequence 4 (BCAS4) Antibody

Sign In for Pricing
View Details
Breast Carcinoma-Amplified Sequence 4 (BCAS4) Antibody
abx014280-02 100 µg

Breast Carcinoma-Amplified Sequence 4 (BCAS4) Antibody

Sign In for Pricing
View Details
Breast Carcinoma-Amplified Sequence 4 (BCAS4) Antibody
abx014280-03 200 µg

Breast Carcinoma-Amplified Sequence 4 (BCAS4) Antibody

Sign In for Pricing
View Details
Breast Carcinoma-Amplified Sequence 4 (BCAS4) Antibody
abx014280-04 300 µg

Breast Carcinoma-Amplified Sequence 4 (BCAS4) Antibody

Sign In for Pricing
View Details